Rahul Shukla, PH.D.

Employment

• Central Drug Research Institute Senior Scientist
  2025 - Present
• CSIR-Central Drug Research Institute Scientist
  2021 - 2025
• International Centre For Genetic Engineering and Biotechnology New Delhi Research Scientist
  2019 - Present
• Icahn School of Medicine at Mount Sinai Department of Microbiology Visiting Scientist
  2019 - Present
• International Centre For Genetic Engineering and Biotechnology New Delhi Research Officer
  2016 - 2019

Education

• International Centre For Genetic Engineering and Biotechnology New Delhi Ph.D.
  2012 - 2016
• University of Lucknow Master of Science (M.Sc.)
  2009 - 2011
• University of Lucknow Bachelor of Science (B.Sc.)
  2006 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Kyasanur Forest Disease Virus: Epidemiological Insights, Pathogenesis, Therapeutic Strategies, and Advances in Vaccines and Diagnostics
  Viruses 2025 DOI: 10.3390/v17081022
  +Save
• Differential Transcriptional Landscape of Vero Cells During Dengue Virus 2 Infection in the Presence of Sinococuline
  Microorganisms 2024 DOI: 10.3390/microorganisms12122529
  +Save
• Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines.
  Vaccines 2023 DOI: 10.3390/vaccines11040742
  +Save
• Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity
  Scientific Reports 2023 DOI: 10.1038/s41598-023-27927-3
  +Save
• Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice
  Frontiers in Immunology 2023 DOI: 10.3389/fimmu.2023.1128784
  +Save
• 'Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity’
  2022 DOI: 10.21203/rs.3.rs-2285709/v1
  +Save
• Cocculus hirsutus-Derived Phytopharmaceutical Drug Has Potent Anti-dengue Activity
  Frontiers in Microbiology 2021 DOI: 10.3389/fmicb.2021.746110
  +Save
• Cocculus hirsutus-derived phytopharmaceutical drug has potent anti-dengue activity
  2020 DOI: 10.1101/2020.09.18.303149
  +Save
• Dengue and Zika Virus Infections Are Enhanced by Live Attenuated Dengue Vaccine but Not by Recombinant DSV4 Vaccine Candidate in Mouse Models
  SSRN 2020 DOI: 10.2139/ssrn.3572852
  +Save
• Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement
  EBioMedicine 2020 DOI: 10.1016/j.ebiom.2020.102738
  +Save